Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kezar Life Sciences Inc.

4.09
-0.2500-5.76%
Post-market: 4.090.00000.00%16:04 EDT
Volume:51.06K
Turnover:211.22K
Market Cap:29.88M
PE:-0.38
High:4.25
Open:4.25
Low:4.01
Close:4.34
Loading ...
Mar 11, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2021

Major Issues Report

8-K - Current report
Nov 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2020

Major Issues Report

8-K - Current report
Sep 21, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2020

Major Issues Report

8-K - Current report
Jun 26, 2020

Major Issues Report

8-K - Current report
Jun 16, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 10, 2020

Major Issues Report

8-K - Current report
Jun 08, 2020

Major Issues Report

8-K - Current report
Jun 03, 2020

Major Issues Report

8-K - Current report
May 07, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Apr 09, 2020

Major Issues Report

Current report, items 2.02, 8.01, and 9.01